Latest news with #chronicillness
Yahoo
a day ago
- General
- Yahoo
The COVID-19 Vaccine Saved My Life. I'm Furious to See it Restricted
It was a few days before Christmas 2021, and I was trying to decide whether I needed to go to the hospital with COVID-19. Through my feverish haze, I watched my blood-oxygen level on my Apple Watch. 90. 89. 88. 92. My husband was isolating in our spare bedroom, leaving food outside my door three times a day. Alone and feeling like a prisoner to illness in my sweat-soaked sheets, I tried to regulate my breathing as I Googled, "when to call 911 COVID-19." By New Year's, I could sit up on my own and greet 2022 from my couch. But it would take weeks before I could walk more than a few steps without gasping like a fish out of water. Another few months before I could get back to something resembling my pre-COVID life. Almost five years later, I still have lasting effects from my first infection. And I've been vaccinated from the very first week my age bracket was allowed to get the jab. I wouldn't wish my ordeal on my worst enemy. But when Health and Human Services Secretary Robert F. Kennedy Jr. abruptly announced this week that he no longer wants the Centers for Disease Control and Prevention to recommend the COVID-19 vaccine for pregnant women and healthy children — which could lead insurers to stop covering their immunizations — it brought those terrifying days rushing back to my memory. I'm the daughter of a healthcare professional, and as a longtime chronic illness warrior, no stranger to the ins and outs of our medical system. But this decision baffles me beyond belief. The data doesn't lie: vaccines work, including against COVID-19. According to 2024-25 CDC data, adults who had taken the vaccine were 33% more likely not to need emergency department or urgent care and 45%–46% effective in preventing hospitalizations among otherwise healthy adults over 65 year old. Previous to Kennedy's recent proclamation, the CDC recommended the vaccine for everyone 6 months and older. As of May 30, the CDC's official position is that people over 6 months old "may" get the vaccine, and there's no longer any guidance for pregnant women. The agency added a condition on vaccinations for healthy children, allowing them to get immunized if they engage in "shared decision-making" with their doctor. RFK Jr. has a long history of vaccine skepticism, and I'm more inclined to take medical advice from doctors and epidemiologists than someone who thought dumping a dead bear cub in Central Park was a good idea. (This is also the same person who claimed to have a brain worm.) Like so many New Yorkers who lived through the terrifying early days of the COVID-19 pandemic in 2020, I'm horrified that we seem to be backpedaling in our defense against this devastating disease. If I never see refrigerator trucks full of corpses parked down the street again, it'll be too soon. So here's a plea to the highest powers we have in this fight: Let's not let political cache get in the way of health. I'm just a girl, standing in front of a computer, pleading for reason. And no, I'm not a doctor, just a patient who never wants to be that sick again. Read the original article on People
Daily Mail
2 days ago
- Health
- Daily Mail
EXCLUSIVE An NFL legend sexually tormented me for years. He did it on the field, in the tunnel and even on TV... but I won't be silenced
Back in 2013, Jenn Sterger went in search of another opinion. Yet another opinion. 'I was constantly in and out of doctors' offices with these rare, chronic illnesses,' the former NFL reporter tells the Daily Mail. No one could quite diagnose the problem.
Yahoo
2 days ago
- Business
- Yahoo
$3.94 Bn IV Hydration Therapy Markets - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F
The IV Hydration Therapy Market is poised for growth due to rising chronic illnesses and surgical volumes, along with numerous new intravenous drug approvals. Expanding IV therapy clinics enhance geographic reach, while technological advancements and personalized solutions boost consumer demand for home-based, individualized care. IV Hydration Therapy Market Dublin, May 30, 2025 (GLOBE NEWSWIRE) -- The "IV Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to offering. The IV Hydration Therapy Market was valued at USD 2.51 Billion in 2024 and is expected to reach USD 3.94 Billion by 2030, rising at a CAGR of 7.80% This growth is primarily attributed to the increasing incidence of chronic illnesses, rising surgical volumes, and the growing number of intravenous drug approvals worldwide. The expansion of IV therapy clinics is also enhancing companies' geographic presence, thereby boosting market penetration. Additionally, the effectiveness and quick response time of IV therapy make it an ideal solution for treating malnutrition and delivering essential nutrients, especially for patients unable to consume food orally. The aging population, with a heightened need for intravenous nutritional support, is further fueling market expansion. A notable example includes Sameday Health's launch of the Inner Beauty IV drip in July 2022, which emphasizes wellness and aesthetic benefits such as improved skin, nails, and hair health, highlighting the increasing consumer focus on preventive and lifestyle healthcare. Key Market Drivers The growing global burden of chronic illnesses and dehydration-related issues significantly drives the demand for IV hydration therapy. Conditions like diabetes, kidney disease, and digestive disorders often result in fluid imbalances, making intravenous hydration essential for effective treatment. According to the World Health Organization, chronic diseases account for 71% of all global deaths, indicating a broad base of potential IV therapy patients. Dehydration is particularly prevalent among elderly individuals, athletes, and those under stress. The CDC reports that older adults are especially susceptible due to reduced thirst sensitivity and coexisting health conditions, which reinforces the importance of accessible and reliable hydration solutions through IV therapy. Key Market Challenges IV hydration therapy faces notable regulatory and safety obstacles that could impede market growth. A lack of consistent regulatory frameworks across different regions raises concerns about the quality and professionalism of services offered. In some areas, IV treatments are administered by staff lacking proper medical training, posing risks such as infections, vein inflammation, or electrolyte imbalances. Furthermore, the U.S. FDA has not approved IV hydration therapy for general wellness applications, underlining the need for more comprehensive clinical research to establish safety and efficacy. Addressing these challenges requires the implementation of standardized protocols and oversight to maintain patient safety and public trust. Key Market Trends Innovations in technology are reshaping the IV hydration therapy market by making treatments more accessible and patient-centric. Portable infusion systems and integration with telemedicine platforms have enabled home-based treatments, broadening the reach of IV therapy. A dditionally, clinics are increasingly offering personalized IV solutions tailored to specific wellness goals, such as immune support, detoxification, and anti-aging. This trend toward customization reflects the rising consumer demand for individualized healthcare experiences, helping drive adoption across various patient segments. Report Scope Key Market Players Core IV Therapy, LLC Cryojuvenate UK B. Braun SE Pfizer, Inc. JW Life Science Amanta Healthcare Vifor Pharma Management Ltd Otsuka Pharmaceutical Co., Ltd. Baxter ICU Medical, Inc. IV Hydration Therapy Market, By Service: Immune Booster Energy Booster Skin Care Others IV Hydration Therapy Market, By Component: Emergency Healthcare Routine Healthcare IV Hydration Therapy Market, By End User: Hospitals & Clinics Wellness Centers & Spa Home Healthcare Others IV Hydration Therapy Market, By Region: North America United States Mexico Canada Europe France Germany United Kingdom Italy Spain Asia-Pacific China India South Korea Japan Australia South America Brazil Argentina Colombia Middle East and Africa South Africa Saudi Arabia UAE Key Attributes: Report Attribute Details No. of Pages 180 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $2.51 Billion Forecasted Market Value (USD) by 2030 $3.94 Billion Compound Annual Growth Rate 7.8% Regions Covered Global For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment IV Hydration Therapy Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Al Jazeera
2 days ago
- General
- Al Jazeera
White House to amend flagship health report citing phantom studies
The United States government has said it will amend a flagship report on children's health that was found to have cited non-existent studies. White House Press Secretary Karoline Leavitt said on Thursday that any citation errors were due to 'formatting issues' and would be updated. The problems with the report will do little to assuage concerns over President Donald Trump's appointment of Robert F Kennedy Jr as Health and Human Services Secretary. The issues with the report, compiled and published last week by the Make America Healthy Again (MAHA) Commission, were revealed by digital news outlet NOTUS. It found that seven studies referenced did not exist, while there were also broken links and 'misstated conclusions'. Leavitt insisted that the problems do 'not negate the substance of the report, which, as you know, is one of the most transformative health reports that has ever been released by the federal government'. The report found that processed food, chemicals, stress and the overprescription of medications and vaccines could be factors behind chronic illness in children, citing more than 500 studies. However, authors credited with producing some of those studies said that they were not part of the research, or that the studies did not exist. Noah Kreski, a Columbia University researcher listed as an author of a paper on adolescent anxiety and depression during COVID-19, told the AFP news agency that the paper was 'not one of our studies' and 'doesn't appear to be a study that exists at all'. The citation for the report included a link to an article in the peer-reviewed JAMA Paediatrics Medical Review that was broken. A spokesperson for the JAMA Network said that the article referenced 'was not published in JAMA Paediatrics or in any JAMA Network journal'. The Democratic National Committee on Thursday slammed the report as 'rife with misinformation', accusing Kennedy's agency of 'justifying its policy priorities with studies and sources that do not exist'. Kennedy's approval as health secretary in February stirred significant controversy. He previously spent decades sowing doubt about the safety of vaccines, raising concerns within the scientific and medical communities over the policies he would pursue. Since taking the role, he has fired thousands of workers at federal health agencies and cut billions of dollars from biomedical research spending. 'The substance of the MAHA report remains the same – a historic and transformative assessment by the federal government to understand the chronic disease epidemic afflicting our nation's children,' the Department of Health and Human Services said.
Reuters
2 days ago
- General
- Reuters
Trump administration report on US child health cited nonexistent studies, media report says
May 29 (Reuters) - A U.S. government report on the health of American children cited scientific studies that did not exist to support its conclusions, according to a media report and some of the purported study authors on Thursday. The report produced by the Make America Healthy Again Commission, named after a movement aligned with Health Secretary Robert F. Kennedy Jr, was released last week. It said processed food, chemicals, stress and overprescription of medications and vaccines may be factors behind chronic illness in American children, citing some 500 research studies as evidence. Digital news outlet NOTUS reported the citation errors, saying on Thursday it found seven studies listed in the report's footnotes that did not exist, along with broken links and misstated conclusions. White House spokesperson Karoline Leavitt told reporters that any citation errors were due to "formatting issues." The government said it posted a corrected version of the report later on Thursday. "The substance of the MAHA report remains the same - a historic and transformative assessment by the federal government to understand the chronic disease epidemic afflicting our nation's children," the Department of Health and Human Services said. Katherine Keyes, an epidemiology professor at the Columbia University Mailman School of Public Health, was cited in the report as the author of "Changes in mental health and substance use among US adolescents during the COVID-19 pandemic," which the report said was published in the medical journal JAMA Pediatrics. She said that neither she nor the named co-authors of the paper had written it. "It does make me concerned given that citation practices are an important part of conducting and reporting rigorous science," she said. Psychiatry Professor Robert L. Findling did not author the article cited in the report as "Direct-to-consumer advertising of psychotropic medications for youth: A growing concern" in the Journal of Child and Adolescent Psychopharmacology, according to a spokesperson for Virginia Commonwealth University, where Findling is a professor. Kennedy has spent decades sowing doubt about the safety of vaccines, raising concerns within the scientific and medical communities over the policies he would pursue as health secretary. Since taking the role, he has fired thousands of workers at federal health agencies and cut billions of dollars from U.S. biomedical research spending. The studies attributed to Findling and Keyes no longer appeared in the MAHA report on the White House website as of Thursday evening.
